These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19762993)

  • 1. The effects of an hsp90 inhibitor on the paradoxical effect.
    Kaneko Y; Ohno H; Imamura Y; Kohno S; Miyazaki Y
    Jpn J Infect Dis; 2009 Sep; 62(5):392-3. PubMed ID: 19762993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Candida-biofilm activity of micafungin is attenuated by voriconazole but restored by pharmacological inhibition of Hsp90-related stress responses.
    Kaneko Y; Ohno H; Fukazawa H; Murakami Y; Imamura Y; Kohno S; Miyazaki Y
    Med Mycol; 2010 Jun; 48(4):606-12. PubMed ID: 19958255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.
    Singh SD; Robbins N; Zaas AK; Schell WA; Perfect JR; Cowen LE
    PLoS Pathog; 2009 Jul; 5(7):e1000532. PubMed ID: 19649312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
    Sandovsky-Losica H; Shwartzman R; Lahat Y; Segal E
    J Antimicrob Chemother; 2008 Sep; 62(3):635-7. PubMed ID: 18490373
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of the paradoxical effect of caspofungin and micafungin on
    Zhouying H; Chen L; Ruiqi W; Kang L; Ji Z
    Indian J Med Microbiol; 2017; 35(2):252-255. PubMed ID: 28681815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of caspofungin and voriconazole against uncommon Candida spp.
    Enache-Angoulvant A; Girard A; Poirot JL; Hennequin C
    Int J Antimicrob Agents; 2009 Jun; 33(6):595-6. PubMed ID: 19162450
    [No Abstract]   [Full Text] [Related]  

  • 8. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
    Lamoth F; Juvvadi PR; Steinbach WJ
    Crit Rev Microbiol; 2016; 42(2):310-21. PubMed ID: 25243616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
    Shuford JA; Piper KE; Steckelberg JM; Patel R
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):277-81. PubMed ID: 17141454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens.
    Ozçelik B; Kaynak F; Cesur S; Sipahi B; Sultan N
    Jpn J Infect Dis; 2007 Sep; 60(5):302-4. PubMed ID: 17881873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-kill studies with micafungin and voriconazole against Candida glabrata intracellularly in human monocyte-derived macrophages and extracellularly in broth.
    Baltch AL; Ritz W; Bopp LH; Michelsen PB; Smith RP
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):468-74. PubMed ID: 21767703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis.
    Gil-Alonso S; Jauregizar N; Eraso E; Quindós G
    PLoS One; 2015; 10(7):e0132730. PubMed ID: 26168269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.
    Beyda ND; Liao G; Endres BT; Lewis RE; Garey KW
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5405-12. PubMed ID: 26100700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rim Pathway Mediates Antifungal Tolerance in Candida albicans through Newly Identified Rim101 Transcriptional Targets, Including Hsp90 and Ipt1.
    Garnaud C; García-Oliver E; Wang Y; Maubon D; Bailly S; Despinasse Q; Champleboux M; Govin J; Cornet M
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi.
    Cowen LE; Lindquist S
    Science; 2005 Sep; 309(5744):2185-9. PubMed ID: 16195452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids.
    Tobudic S; Forstner C; Schranz H; Poeppl W; Vychytil A; Burgmann H
    Mycoses; 2013 Nov; 56(6):623-30. PubMed ID: 23551835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.